Hafrun Fridriksdottir - Mar 4, 2022 Form 4 Insider Report for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Signature
/s/ Dov Bergwerk as attorney-in-fact for Hafrun Fridriksdottir
Stock symbol
TEVA
Transactions as of
Mar 4, 2022
Transactions value $
-$250,219
Form type
4
Date filed
3/8/2022, 03:07 PM
Previous filing
Mar 2, 2022
Next filing
May 19, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TEVA Ordinary Shares Options Exercise +51.5K +78.6% 117K Mar 4, 2022 Direct F1, F2
transaction TEVA Ordinary Shares Sale -$135K -18K -15.4% $7.48 99K Mar 4, 2022 Direct F1, F3, F4, F5
transaction TEVA Ordinary Shares Options Exercise +18.9K +19.1% 118K Mar 4, 2022 Direct F1, F2
transaction TEVA Ordinary Shares Sale -$49.5K -6.62K -5.61% $7.48 111K Mar 4, 2022 Direct F1, F3, F4, F5
transaction TEVA Ordinary Shares Options Exercise +23.8K +21.36% 135K Mar 5, 2022 Direct F1, F2
transaction TEVA Ordinary Shares Sale -$65.9K -8.94K -6.62% $7.37 126K Mar 7, 2022 Direct F1, F3, F4, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TEVA Restricted Share Units Options Exercise $0 -51.5K -100% $0.00* 0 Mar 4, 2022 Ordinary Shares 51.5K Direct F1, F2, F7
transaction TEVA Restricted Share Units Options Exercise $0 -18.9K -50% $0.00 18.9K Mar 4, 2022 Ordinary Shares 18.9K Direct F1, F2, F8
transaction TEVA Restricted Share Units Award $0 +141K $0.00 141K Mar 4, 2022 Ordinary Shares 141K Direct F1, F2, F9
transaction TEVA Restricted Share Units Options Exercise $0 -23.8K -25% $0.00 71.3K Mar 5, 2022 Ordinary Shares 23.8K Direct F1, F2, F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2 Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
F3 The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F4 Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.40 to $7.60, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.30 to $7.49, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
F7 Restricted share units were received on February 8, 2022 upon satisfaction of performance criteria and vested on March 4, 2022.
F8 Restricted share units were granted on March 4, 2019, with 18,905 having vested on each of March 4, 2021 and March 4, 2022, and 18,906 vesting on March 4, 2023.
F9 Restricted share units were granted on March 4, 2022, with 35,187 vesting on each of March 4, 2023, March 4, 2024 and March 4, 2025, and 35,189 vesting on March 4, 2026.
F10 Restricted share units were granted on March 5, 2021, with 23,764 having vested on March 5, 2022, 23,764 vesting on each of March 5, 2023 and March 5, 2024, and 23,765 vesting on March 5, 2025.